Application 207771

Type
ANDA
Sponsor
ZYDUS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;20MGNoNo
002AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 5MG BASE;40MGNoNo
003AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;20MGNoNo
004AMLODIPINE AND OLMESARTAN MEDOXOMILAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILTABLET;ORALEQ 10MG BASE;40MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68382-927Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-927Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals USA Inc.ANDACurrent
68382-927Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-928Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-928Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-928Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals USA Inc.ANDACurrent
68382-929Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-929Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-929Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals USA Inc.ANDACurrent
68382-930Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-930Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-930Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Pharmaceuticals USA Inc.ANDACurrent
70771-1186Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Lifesciences LimitedANDACurrent
70771-1186Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1186Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1186Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1187Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1187Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1187Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Lifesciences LimitedANDACurrent
70771-1187Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1188Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1188Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1188Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Lifesciences LimitedANDACurrent
70771-1188Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1189Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1189Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent
70771-1189Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilZydus Lifesciences LimitedANDACurrent
70771-1189Amlodipine and olmesartan medoxomilAmlodipine and olmesartan medoxomilCadila Healthcare LimitedANDACurrent